Presentation is loading. Please wait.

Presentation is loading. Please wait.

Immunosuppression significantly reduced all-cause mortality or risk of ESRD (A) and significantly increased complete or partial remission (B) at the end.

Published byΚυρία Ανδρέου Modified over 5 years ago

Similar presentations

Presentation on theme: "Immunosuppression significantly reduced all-cause mortality or risk of ESRD (A) and significantly increased complete or partial remission (B) at the end."— Presentation transcript:

1 Immunosuppression significantly reduced all-cause mortality or risk of ESRD (A) and significantly increased complete or partial remission (B) at the end of follow-up compared with no treatment or ACEI. ACEI, angiotensin converting enzyme inhibitor; CI, conf... Immunosuppression significantly reduced all-cause mortality or risk of ESRD (A) and significantly increased complete or partial remission (B) at the end of follow-up compared with no treatment or ACEI. ACEI, angiotensin converting enzyme inhibitor; CI, confidence interval; IV, inverse variance method. Yizhi Chen et al. CJASN 2013;8: ©2013 by American Society of Nephrology

Download ppt "Immunosuppression significantly reduced all-cause mortality or risk of ESRD (A) and significantly increased complete or partial remission (B) at the end."

Similar presentations

Management of IgA nephropathy: Evidence-based recommendations

Management of IgA nephropathy: Evidence-based recommendations
Figure 1. Serum creatinine trend in the patient

Figure 1. Serum creatinine trend in the patient
Results of random-effects meta-analysis of association between use of angiotensin-converting-enzyme (ACE) inhibitors or angiotensin-receptor blockers and.

Results of random-effects meta-analysis of association between use of angiotensin-converting-enzyme (ACE) inhibitors or angiotensin-receptor blockers and.
Among Medicare beneficiaries >65 years old with a index hospitalization at the time of dialysis initiation, use of post-acute SNF care was common. Among.

Among Medicare beneficiaries >65 years old with a index hospitalization at the time of dialysis initiation, use of post-acute SNF care was common. Among.
Positive interactions between the basic and translational research, clinical research, patient care, and training components of an academic dialysis access.

Positive interactions between the basic and translational research, clinical research, patient care, and training components of an academic dialysis access.
Adjusted all-cause mortality risk by dialysate sodium (DNa) and predialysis serum sodium (SNa). Adjusted all-cause mortality risk by dialysate sodium (DNa)

Adjusted all-cause mortality risk by dialysate sodium (DNa) and predialysis serum sodium (SNa). Adjusted all-cause mortality risk by dialysate sodium (DNa)
Probability of cumulative incidence of ESRD, disease-related death, or death from other cause for the entire cohort. Probability of cumulative incidence.

Probability of cumulative incidence of ESRD, disease-related death, or death from other cause for the entire cohort. Probability of cumulative incidence.
Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical.

Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical.
Shadi Al Halabi et al. JACEP 2015;1:

Shadi Al Halabi et al. JACEP 2015;1:
Membranous nephropathy: When and how to treat

Membranous nephropathy: When and how to treat
David J. Tunnicliffe, Suetonia C. Palmer 

David J. Tunnicliffe, Suetonia C. Palmer 
Volume 81, Issue 7, Pages (April 2012)

Volume 81, Issue 7, Pages (April 2012)
Impact of Preoperative Angiotensin-Converting Enzyme Inhibitor Use on Clinical Outcomes After Cardiac Surgery  Maral Ouzounian, MD, Karen J. Buth, MS,

Impact of Preoperative Angiotensin-Converting Enzyme Inhibitor Use on Clinical Outcomes After Cardiac Surgery  Maral Ouzounian, MD, Karen J. Buth, MS,
Patterns of mortal risk among eKt/V quintiles in the HEMO study for (A) 1 yr of follow-up and (B) after 1 yr. Patterns of mortal risk among eKt/V quintiles.

Patterns of mortal risk among eKt/V quintiles in the HEMO study for (A) 1 yr of follow-up and (B) after 1 yr. Patterns of mortal risk among eKt/V quintiles.
Audit-based education: a potentially effective program for improving guideline achievement in CKD patients  Moniek C.M. de Goeij, Joris I. Rotmans  Kidney.

Audit-based education: a potentially effective program for improving guideline achievement in CKD patients  Moniek C.M. de Goeij, Joris I. Rotmans  Kidney.
Adjusted rate ratios of hospital days and admissions for blacks and Hispanics compared with whites by age group. Adjusted rate ratios of hospital days.

Adjusted rate ratios of hospital days and admissions for blacks and Hispanics compared with whites by age group. Adjusted rate ratios of hospital days.
Volume 80, Issue 9, Pages (November 2011)

Volume 80, Issue 9, Pages (November 2011)
Volume 94, Issue 3, Pages (September 2018)

Volume 94, Issue 3, Pages (September 2018)
Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical.

Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical.
Prabhat Kumar et al. JACEP 2016;j.jacep

Prabhat Kumar et al. JACEP 2016;j.jacep

Similar presentations

Ads by Google